Literature DB >> 16204683

Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?

Dan L Longo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16204683     DOI： 10.1093/jnci/dji310

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

2.  The case for combined-modality therapy for limited-stage Hodgkin's disease.

Authors:  Christine E Hill-Kayser; John P Plastaras; Zelig Tochner; Eli Glatstein
Journal:  Oncologist       Date:  2012-07-17

Review 3.  Testicular cancer survivorship: research strategies and recommendations.

Authors:  Lois B Travis; Clair Beard; James M Allan; Alv A Dahl; Darren R Feldman; Jan Oldenburg; Gedske Daugaard; Jennifer L Kelly; M Eileen Dolan; Robyn Hannigan; Louis S Constine; Kevin C Oeffinger; Paul Okunieff; Greg Armstrong; David Wiljer; Robert C Miller; Jourik A Gietema; Flora E van Leeuwen; Jacqueline P Williams; Craig R Nichols; Lawrence H Einhorn; Sophie D Fossa
Journal:  J Natl Cancer Inst       Date:  2010-06-28       Impact factor: 13.506

4.  Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.

Authors:  Moo-Kon Song; Joo-Seop Chung; Je-Jung Lee; Shin Young Jeong; Sang-Min Lee; Jun-Shik Hong; Ari Chong; Joon-Ho Moon; Ji-Hyun Kim; Seok-Mo Lee; Seong Jang Kim; Ho-Jin Shin
Journal:  Cancer Sci       Date:  2013-10-23       Impact factor: 6.716

5.  Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).

Authors:  Leo I Gordon; Fangxin Hong; Richard I Fisher; Nancy L Bartlett; Joseph M Connors; Randy D Gascoyne; Henry Wagner; Patrick J Stiff; Bruce D Cheson; Mary Gospodarowicz; Ranjana Advani; Brad S Kahl; Jonathan W Friedberg; Kristie A Blum; Thomas M Habermann; Joseph M Tuscano; Richard T Hoppe; Sandra J Horning
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.